Coronavirus Update: Moderna's Vaccine Frontrunner Gets Fast-Tracked, Wuhan To Test Millions

Plus China Tighthens Biosafety Standards, Aimmune Pauses Launch

Moderna gets green light to proceed to Phase II trial of mRNA vaccine, with its eagerly-awaited Phase I results expected shortly.

Wuhan_Social_Distancing
Wuhan, China: Isolated new outbreaks of COVID-19 have occurred, and now authorities aim to test most of the city's 11 million inhabitants.

The US Food and Drug Administration has granted fast-track designation to Moderna Inc.’s coronavirus vaccine candidate mRNA-1273.

The novel mRNA-based vaccine is one of the most advanced in the industry’s COVID-19 pipeline, making Moderna the center of...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip